Post-Marketing Requirements (PMRs) typically address what aspect?

Post-Marketing Requirements (PMRs) typically address what aspect?

• A. Marketing strategies
• B. Safety concerns of drugs
• C. Manufacturing scale-up
• D. Intellectual property

Answer: (B)

PMRs are commitments to gather additional safety information once a drug is approved, focusing on how the drug performs in real-world use. They aim to detect rare or long-term adverse effects and ensure the benefit–risk balance remains favorable across broader patient populations. This often involves postmarketing studies, safety surveillance, patient registries, and other activities that monitor adverse events and use patterns after approval. The other options relate to marketing tactics, manufacturing scale-up, or intellectual property, not the safety-focused purpose of PMRs.

PMRs are commitments to gather additional safety information once a drug is approved, focusing on how the drug performs in real-world use. They aim to detect rare or long-term adverse effects and ensure the benefit–risk balance remains favorable across broader patient populations. This often involves postmarketing studies, safety surveillance, patient registries, and other activities that monitor adverse events and use patterns after approval. The other options relate to marketing tactics, manufacturing scale-up, or intellectual property, not the safety-focused purpose of PMRs.